Company / Book Value per Share
CUMBERLAND PHARMACEUTICALS INC Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.783
FY2025
5-year range
$1.618 / $2.856
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share returned to growth in FY2025 after 8 years of decline, reaching $1.783.
Based on SEC 10-K filings.
$1.783 in FY2025 with a 5-year CAGR of -10.3%.
Declined from $2.061 to $1.783 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -10.2%
- 5-Year CAGR
- -10.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -10.3%, indicating a declining trend.
- In FY2025, book value per share increased 10.2% year-over-year.
- Peak book value per share was recorded in FY2016.
- Lowest book value per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.783 | +10.2% |
| FY2024 | $1.618 | -21.5% |
| FY2023 | $2.061 | -16.2% |
| FY2022 | $2.46 | -13.9% |
| FY2021 | $2.856 | -7.2% |
| FY2020 | $3.079 | -6.8% |
| FY2019 | $3.302 | -5.0% |
| FY2018 | $3.474 | -12.9% |
| FY2017 | $3.989 | -10.8% |
| FY2016 | $4.472 | -0.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026